Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Down syndrome critical region gene 6 pseudogene (ENSG00000270713) is a non-coding pseudogene mapped to the "Down syndrome critical region." It is annotated in genomic databases as a non-functional remnant related to the DGCR6 gene, known for its role in neural crest cell migration and developmental processes in its active (protein-coding) form[2]. However, this pseudogene itself has no evidence for protein expression, biological function, or direct involvement in disease, and is not considered a valid therapeutic target. Its primary significance is as a genomic marker or annotation rather than a functional molecule. Summary: This entry refers to a pseudogene; therefore, it is not a protein, receptor, or functional biomolecule, and is not a current or prospective therapeutic target[2]. The target name is technically valid as a pseudogene but not suited for therapeutic or diagnostic development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Down syndrome critical region gene 6 pseudogene.